TrialZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China].

H Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.